Nanologix Valuation
| NNLX Stock | USD 0.0001 0.00 0.00% |
Nanologix seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Nanologix from analyzing the firm fundamentals such as Return On Equity of -2.14, current valuation of (166.24 K), and Price To Earning of (3.24) X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Nanologix's price fluctuation is out of control at this time. Calculation of the real value of Nanologix is based on 3 months time horizon. Increasing Nanologix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nanologix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nanologix Pink Sheet. However, Nanologix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 6.3E-5 | Hype 1.0E-4 |
The intrinsic value of Nanologix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nanologix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nanologix helps investors to forecast how Nanologix pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nanologix more accurately as focusing exclusively on Nanologix's fundamentals will not take into account other important factors: Nanologix Total Value Analysis
Nanologix is now expected to have valuation of (166.24 K) with market capitalization of 15.88 K, debt of 0, and cash on hands of 178.19 K. The negative valuation of Nanologix may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Nanologix fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(166.24 K) | 15.88 K | 0 | 178.19 K |
Nanologix Investor Information
The company recorded a loss per share of 0.02. Nanologix had not issued any dividends in recent years. Based on the key measurements obtained from Nanologix's financial statements, Nanologix is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Nanologix Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nanologix has an asset utilization ratio of 0.0968 percent. This suggests that the Company is making $9.68E-4 for each dollar of assets. An increasing asset utilization means that Nanologix is more efficient with each dollar of assets it utilizes for everyday operations.Nanologix Profitability Analysis
The company reported the previous year's revenue of 892. Net Loss for the year was (1.86 M) with loss before overhead, payroll, taxes, and interest of (99.13 K).About Nanologix Valuation
Our relative valuation model uses a comparative analysis of Nanologix. We calculate exposure to Nanologix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nanologix's related companies.NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. Nanologix operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Nanologix's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nanologix's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nanologix's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nanologix's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nanologix's revenue streams: Identify Nanologix's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nanologix's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nanologix's growth potential: Evaluate Nanologix's management, business model, and growth potential.
- Determine Nanologix's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nanologix's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nanologix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -23.9 M |
Additional Tools for Nanologix Pink Sheet Analysis
When running Nanologix's price analysis, check to measure Nanologix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanologix is operating at the current time. Most of Nanologix's value examination focuses on studying past and present price action to predict the probability of Nanologix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanologix's price. Additionally, you may evaluate how the addition of Nanologix to your portfolios can decrease your overall portfolio volatility.